Plans for £6m chicken farm near university
The four proposed poultry units would be built on land near Harper Adams University, close to Newport, Shropshire.
Meese Farming, a Lilleshall-based firm, submitted the plans to Telford and Wrekin Council and a public consultation has begun on them.
The university itself "expressed strong support for the scheme", planning agent Ian Pick said, in his report for the council's planners.
Harper Adams will not build or run the farm but it favours the plans due to their "significant value as a teaching and research resource for both agricultural and veterinary students", he added.
The university specialises in agriculture and the rural economy.
The proposed farm includes a teaching facility and a viewing area which will be able to be used by students from schools, colleges, and universities, Mr Pick added.
Meese Farming also has a poultry unit at Deepdale Farm in nearby Chetwynd.
The proposed farm will see about £6m spent on the buildings and other facilities at the site, planning documents show.
The business will also need an Environment Agency permit in order to operate.
Meese Farming proposed that the water on its new site would drain through a sealed network, filter drains and filter strips "in order to minimise the risk of contamination to the final watercourse".
Their plans come as river campaigners in Shropshire and Herefordshire have in recent years called for action to protect local waterways from the potential effects of chicken farming and chicken manure.
Campaigners in June won a High Court battle to overturn planning permission for an industrial-scale chicken farm in Felton Butler, near Shrewsbury.
This news was gathered by the Local Democracy Reporting Service, which covers councils and other public service organisations.
Follow BBC Shropshire on BBC Sounds, Facebook, X and Instagram.
River campaigners win chicken farm legal challenge
Rural cinemas holding film nights for farmers
Farmers' tractor demo over tax row goes to council
Telford & Wrekin Council
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31
Dynavax Technologies Corporation (NASDAQ:DVAX) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 23, Citizens JMP analyst Roy Buchanan reiterated a Buy rating on Dynavax Technologies Corporation (NASDAQ:DVAX) and set a price target of $31.00. A biopharmaceutical company executive signing a collaboration agreement with a partner. The company reported record net product revenue for HEPLISAV-B in fiscal Q1 2025, reaching $65 million and showing a 36% year-over-year growth. HEPLISAV-B is the first and only adult vaccine for hepatitis B approved in the US, the UK, and the EU. Its total estimated market share in the US rose to around 43%, compared to around 41% in fiscal Q1 2024. Dynavax Technologies Corporation (NASDAQ:DVAX) also announced plans for the new pandemic influenza adjuvant program and Lyme disease vaccine programs to enter clinical development in 2025 and 2027, respectively. In addition, the company expects top-line results in Part 1 of the Phase 1/2 shingles vaccine trial by fiscal Q3 2025. Dynavax Technologies Corporation (NASDAQ:DVAX) is a biopharmaceutical company that discovers, develops, and commercializes novel vaccines and immuno-oncology therapeutics. The company's product pipeline includes HEPLISAV-B, a vaccine for all known subtypes of the hepatitis B virus in adults aged 18 and above. While we acknowledge the potential of DVAX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
26 minutes ago
- Yahoo
Do SpaceandPeople's (LON:SAL) Earnings Warrant Your Attention?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. While a well funded company may sustain losses for years, it will need to generate a profit eventually, or else investors will move on and the company will wither away. In contrast to all that, many investors prefer to focus on companies like SpaceandPeople (LON:SAL), which has not only revenues, but also profits. While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. That makes EPS growth an attractive quality for any company. Impressively, SpaceandPeople has grown EPS by 17% per year, compound, in the last three years. As a general rule, we'd say that if a company can keep up that sort of growth, shareholders will be beaming. One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. EBIT margins for SpaceandPeople remained fairly unchanged over the last year, however the company should be pleased to report its revenue growth for the period of 15% to UK£6.7m. That's encouraging news for the company! You can take a look at the company's revenue and earnings growth trend, in the chart below. Click on the chart to see the exact numbers. View our latest analysis for SpaceandPeople SpaceandPeople isn't a huge company, given its market capitalisation of UK£2.3m. That makes it extra important to check on its balance sheet strength. Seeing insiders owning a large portion of the shares on issue is often a good sign. Their incentives will be aligned with the investors and there's less of a probability in a sudden sell-off that would impact the share price. So we're pleased to report that SpaceandPeople insiders own a meaningful share of the business. To be exact, company insiders hold 51% of the company, so their decisions have a significant impact on their investments. This makes it apparent they will be incentivised to plan for the long term - a positive for shareholders with a sit and hold strategy. Of course, SpaceandPeople is a very small company, with a market cap of only UK£2.3m. That means insiders only have UK£1.2m worth of shares, despite the large proportional holding. That might not be a huge sum but it should be enough to keep insiders motivated! If you believe that share price follows earnings per share you should definitely be delving further into SpaceandPeople's strong EPS growth. This EPS growth rate is something the company should be proud of, and so it's no surprise that insiders are holding on to a considerable chunk of shares. Fast growth and confident insiders should be enough to warrant further research, so it would seem that it's a good stock to follow. Don't forget that there may still be risks. For instance, we've identified 2 warning signs for SpaceandPeople (1 is significant) you should be aware of. There's always the possibility of doing well buying stocks that are not growing earnings and do not have insiders buying shares. But for those who consider these important metrics, we encourage you to check out companies that do have those features. You can access a tailored list of British companies which have demonstrated growth backed by significant insider holdings. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. — Investing narratives with Fair Values Suncorp's Next Chapter: Insurance-Only and Ready to Grow By Robbo – Community Contributor Fair Value Estimated: A$22.83 · 0.1% Overvalued Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth By Chris1 – Community Contributor Fair Value Estimated: €14.40 · 0.3% Overvalued Tesla's Nvidia Moment – The AI & Robotics Inflection Point By BlackGoat – Community Contributor Fair Value Estimated: $359.72 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Lloyds Banking Group, Lumio Partner to Enhance Financial Management for Couples
Lloyds Banking Group (NYSE:LYG) is one of the cheap penny stocks to buy now. Towards the end of May, Lloyds Banking Group announced a partnership with Lumio, which is a financial management application, to enhance money management for couples and households. The collaboration aims to simplify shared financial management. The new initiative is to be introduced to select Lloyds customers who manage joint bills, with a rollout scheduled between May and August this year. During this period, participants will receive a complimentary trial of Lumio Couples Pro. The Lumio app currently serves 40,000+ couples. Users can utilize a real-time IOU tracker to split expenses and aim to reduce disputes by providing an accurate record of financial transactions for both parties. An aerial shot of a business district with the company's headquarters towering above its competitors. Lumio is a graduate of the Lloyds 2024 Launch Innovation programme, which facilitates commercial experiments between selected fintech startups and Lloyds Banking Group. Lloyds also unveiled the next cohort of startups for its 2025 Launch Innovation programme, which focuses on supporting emerging fintech and insurtech companies with expert guidance and resources. Lloyds Banking Group (NYSE:LYG) provides a range of banking & financial products and services in the UK and internationally. While we acknowledge the potential of LYG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
